Company intelligence / Profile preview
Shivanka Research
Sanand/Ahmedabad, Gujarat, Indiashivankaresearch.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
KSHN001126 has shown promising efficacy in preclinical models and is currently in Phase I clinical trials for advanced ER+/HER2– breast cancer. The company also reports positive preclinical data on other assets targeting rare diseases and women’s health conditions.
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Small moleculesChemical drugs
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Shivanka Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shivanka Research.